[Bronchial asthma and experimental evaluation of the antibronchospastic action of adrenaline, atropine and papaverine alone and in combinations].
D000420:Albuterol / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001285:Atropine / Q000627:therapeutic use*; D001986:Bronchial Spasm / Q000139:chemically induced / Q000188:drug therapy*; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D004837:Epinephrine / Q000627:therapeutic use*; D006168:Guinea Pigs; D006632:Histamine; D007545:Isoproterenol / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use*; D012701:Serotonin; D013726:Terbutaline / Q000627:therapeutic use
D004338:Drug Combinations; D012701:Serotonin; D009921:Metaproterenol; D001285:Atropine; D006632:Histamine; D010208:Papaverine; D007545:Isoproterenol; D013726:Terbutaline; D000420:Albuterol; D004837:Epinephrine
Considerazioni sull'asma bronchiale e valutazione sperimentale in senso antibroncospastico dell'adrenalina, dell'atropina e della papaverina da sole o associate